| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1590/S0100-879X1998000300002 |
| P698 | PubMed publication ID | 9698780 |
| P2093 | author name string | M M Rodrigues | |
| I S Soares | |||
| P2860 | cites work | Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein | Q24563514 |
| The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes | Q29393314 | ||
| Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes | Q29618991 | ||
| Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins | Q33598899 | ||
| The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites | Q34237481 | ||
| Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group | Q34397061 | ||
| Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria | Q34620173 | ||
| The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules | Q36231136 | ||
| Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria | Q36343961 | ||
| A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. | Q36352078 | ||
| Malaria vaccine trials: the missing qualitative data | Q36827211 | ||
| The effect of insecticide-treated bed nets on mortality of Gambian children | Q38870607 | ||
| Efficacy trial of malaria vaccine SPf66 in Gambian infants | Q38959070 | ||
| Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. | Q39340864 | ||
| Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides | Q40433315 | ||
| Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. | Q40694949 | ||
| Malaria vaccines: multiple targets | Q40695819 | ||
| T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages | Q40898245 | ||
| The role of TH1 and TH2 cells in a rodent malaria infection. | Q41546942 | ||
| Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals | Q42006764 | ||
| Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes | Q42938913 | ||
| Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus | Q43409506 | ||
| Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites | Q44146544 | ||
| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group | Q44174498 | ||
| Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes | Q44174540 | ||
| CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria | Q47863985 | ||
| Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria | Q47910752 | ||
| Immunization against blood-stage rodent malaria using purified parasite antigens | Q47996405 | ||
| Target antigens for asexual malaria vaccine development | Q47996640 | ||
| The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite | Q47998652 | ||
| Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. | Q48002865 | ||
| Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine | Q48004555 | ||
| Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. | Q48014958 | ||
| Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. | Q48028231 | ||
| Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains | Q48202726 | ||
| Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses | Q56877444 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| malaria vaccine | Q6741353 | ||
| P304 | page(s) | 317-332 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Brazilian Journal of Medical and Biological Research | Q2025772 |
| P1476 | title | Malaria vaccine: roadblocks and possible solutions | |
| P478 | volume | 31 |
| Q47893571 | Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors |
| Q43733553 | Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance |
| Q34070173 | Transfectant influenza viruses as antigen delivery vectors |
Search more.